LIVENT Stock price Nyse

Equities

LTHM

US53814L1089

Specialty Chemicals

Delayed Nyse 04:00:13 2024-01-03 pm EST 5-day change 1st Jan Change
16.51 USD -8.53% Intraday chart for LIVENT +140.60% +120.93%
Sales 2024 * 1.3B Sales 2025 * 1.86B Capitalization 6.56B
Net income 2024 * 276M Net income 2025 * 573M EV / Sales 2024 * 4.92 x
Net cash position 2024 * 164M Net Debt 2025 * 156M EV / Sales 2025 * 3.62 x
P/E ratio 2024 *
14.7 x
P/E ratio 2025 *
7.12 x
Employees 1,470
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.86%
More Fundamentals * Assessed data
Dynamic Chart
1 day-8.53%
1 week+140.60%
Current month+140.60%
1 month+140.60%
3 months+121.92%
6 months+132.43%
Current year+120.93%
More quotes
Current year
6.52
Extreme 6.517
17.51
1 year
5.30
Extreme 5.3013
17.51
3 years
5.30
Extreme 5.3013
17.51
5 years
1.64
Extreme 1.6417
17.51
10 years
1.64
Extreme 1.6417
17.51
More quotes
Arcadium Lithium PLC is a global lithium chemicals producer with a diversified product offering. The Company’s diverse set of products include lithium hydroxide, carbonate, spodumene and specialties. The Company produces a diverse set of lithium products, such as lithium specialties, lithium hydroxide, lithium carbonate, and spodumene. The Company’s products applications include butyllithium, purified metals, specialty organics, battery grade lithium hydroxide, other lithium hydroxide, battery grade lithium carbonate, other lithium carbonate, and intermediate product for conversion to lithium hydroxide/carbonate. It also focuses on conventional brine extraction, direct lithium brine extraction, hard rock mining, chemical processing and production of battery grade and specialty lithium products. It has a presence in three lithium extraction geographies, including the South American Lithium Triangle, Western Australia and Canada.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
4.43 USD
Average target price
8.276 USD
Spread / Average Target
+86.81%
Consensus